DNA from Bacteria in Brain May Promote Tau Clumping, Study Suggests
DNA from various species of bacteria, some of which — like E. coli — have been identified in the brains of Alzheimer’s patients, can cause ... Read more
Updates
-
-
New Carbon Nanotube Sensor Ably Spots Alzheimer’s via Proteins in Blood, Study Reports
A new biosensor using neatly aligned carbon nanotubes may bring scientists one step closer to a blood test for the early detection of Alzheimer’s disease. ... Read more -
Phase 2 Trial into Potential Oral Alzheimer’s Treatment Safe to Continue, Independent Board Says
A Phase 2 clinical trial testing Annovis Bio‘s oral therapy ANV401 (also known as Posiphen) in people with early Alzheimer’s disease can continue without changes, ... Read more -
Should Loved Ones with Alzheimer’s Pitch in with Chores?
When my children were little, I would ask them to help me with the mundane but necessary tasks that came with everyday living. “Please ... Read more -
Solanezumab and Gantenerumab Fail to Slow Memory Loss or Cognitive Decline in Early-onset Alzheimer’s, Study Finds
Two investigational treatments, solanezumab and gantenerumab, failed to prevent memory loss or cognitive decline in patients with a rare, inherited form of early-onset Alzheimer’s ... Read more
-
Biogen to Start Re-dosing Aducanumab in Alzheimer’s Patients From Halted Trials
Biogen will soon launch an open-label trial to start re-dosing aducanumab — an injectable ... -
Number of Dementia Cases Likely to Double by 2050 as Europe Ages, Report Says
The number of people with dementia in 37 countries in and near Europe is ... -
Cortexyme Advances COR388 Clinical Development Program in Alzheimer’s Disease After FDA Meeting
Following feedback from the U.S. Food and Drug Administration (FDA), Cortexyme will conduct an ... -
Small Gestures on Valentine’s Day Can Mean a Lot to Caregivers
Remember when pink and white tissue paper was all you needed for a successful ... -
Scientists Use CRISPR-Cas9 as ‘DNA Scissors’ to Cut Out Alzheimer’s Gene in Mice, Study Shows
Using the gene editing technology CRISPR-Cas9 like a pair of “DNA scissors,” researchers were ... -
Chaperone Works to Lessen Alzheimer’s Symptoms and Toxic Protein Buildup, Mouse Study Says
A molecular chaperone called TPT-172 was able to prevent proteins linked to Alzheimer’s — including amyloid-beta and ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
Anavex ‘Cautiously Optimistic’ After Noting Cognitive Improvement in Alzheimer’s Treatment
News
Anavex Life Sciences says its Alzheimer’s drug candidate Anavex 2-73 may have a role in treating the disease. Data from a long-term extension trial, although small, indicated that the therapy improved cognitive and functional measures in patients. According to data ... Read more